[HTML][HTML] Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroinflammation
T Assone, SM Menezes, F de Toledo Gonçalves… - Journal of …, 2022 - Springer
Abstract Background HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
(HAM/TSP) is an incapacitating neuroinflammatory disorder for which no disease-modifying …
(HAM/TSP) is an incapacitating neuroinflammatory disorder for which no disease-modifying …
Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroinflammation.
T Assone, SM Menezes… - Journal of …, 2022 - search.ebscohost.com
Abstract Background: HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
(HAM/TSP) is an incapacitating neuroinflammatory disorder for which no disease-modifying …
(HAM/TSP) is an incapacitating neuroinflammatory disorder for which no disease-modifying …
[HTML][HTML] Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroinflammation
T Assone, SM Menezes… - Journal of …, 2022 - jneuroinflammation.biomedcentral …
HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) is an
incapacitating neuroinflammatory disorder for which no disease-modifying therapy is …
incapacitating neuroinflammatory disorder for which no disease-modifying therapy is …
Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroinflammation
T Assone, SM Menezes, F Toledo, VA Folgosi… - 2022 - researchsquare.com
Background: HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) is an
incapacitating neuroinflammatory disorder for which no disease-modifying therapy is …
incapacitating neuroinflammatory disorder for which no disease-modifying therapy is …
Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroinflammation.
T Assone, S Menezes… - Journal of …, 2022 - escholarship.org
BACKGROUND: HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) is
an incapacitating neuroinflammatory disorder for which no disease-modifying therapy is …
an incapacitating neuroinflammatory disorder for which no disease-modifying therapy is …
Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroinflammation
T Assone, SM Menezes… - Journal of …, 2022 - search.proquest.com
Background HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) is an
incapacitating neuroinflammatory disorder for which no disease-modifying therapy is …
incapacitating neuroinflammatory disorder for which no disease-modifying therapy is …
[PDF][PDF] Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroin ammation
T Assone, SM Menezes, F Toledo, VA Folgosi… - academia.edu
Abstract Background: HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
(HAM/TSP) is an incapacitating neuroin ammatory disorder for which no disease-modifying …
(HAM/TSP) is an incapacitating neuroin ammatory disorder for which no disease-modifying …
[HTML][HTML] Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroinflammation
T Assone, SM Menezes… - Journal of …, 2022 - ncbi.nlm.nih.gov
Background HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) is an
incapacitating neuroinflammatory disorder for which no disease-modifying therapy is …
incapacitating neuroinflammatory disorder for which no disease-modifying therapy is …
Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroinflammation.
T Assone, SM Menezes… - Journal of …, 2022 - europepmc.org
Background HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) is an
incapacitating neuroinflammatory disorder for which no disease-modifying therapy is …
incapacitating neuroinflammatory disorder for which no disease-modifying therapy is …
[PDF][PDF] Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroin ammation
T Assone, SM Menezes, F Toledo, VA Folgosi… - scholar.archive.org
Abstract Background: HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
(HAM/TSP) is an incapacitating neuroin ammatory disorder for which no disease-modifying …
(HAM/TSP) is an incapacitating neuroin ammatory disorder for which no disease-modifying …